| 11/09/2026 6:52 AM | ImmunityBio (1326110) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 6:39 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/09/2026 5:33 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/14/2026 4:19 PM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/06/2026 5:05 PM | Cohen Cheryl (1529371) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/06/2026 5:06 PM | ImmunityBio (1326110) Issuer Simon Barry J. (1647994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 9:21 AM | ImmunityBio (1326110) Subject Simon Barry J. (1647994) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/06/2026 5:50 PM | Cambridge Equities, LP (1629222) Filed by ImmunityBio (1326110) Subject | Form SCHEDULE 13D/A | |
| 08/04/2026 6:45 AM | ImmunityBio (1326110) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2026 6:36 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/30/2026 4:19 PM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for IBRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ImmunityBio and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/06/2026 7:25 PM | ImmunityBio (1326110) Issuer Selecky Christobel (1849739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 7:26 PM | Cohen Cheryl (1529371) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 4:04 PM | ImmunityBio (1326110) Issuer Selecky Christobel (1849739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 3:35 PM | ImmunityBio (1326110) Subject Selecky Christobel (1849739) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 3:44 PM | ImmunityBio (1326110) Subject Selecky Christobel (1849739) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 8:00 PM | ImmunityBio (1326110) Issuer Simon Barry J. (1647994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 7:11 PM | ImmunityBio (1326110) Issuer Selecky Christobel (1849739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 7:11 PM | Cohen Cheryl (1529371) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 7:11 PM | Clark Wesley (1349193) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 7:11 PM | ImmunityBio (1326110) Issuer MAXWELL LINDA (1822674) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 7:11 PM | ImmunityBio (1326110) Issuer Wendel Bruce (1364846) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 7:11 PM | BLASZYK MICHAEL D (1371407) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 4:24 PM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/05/2026 4:29 PM | ImmunityBio (1326110) Issuer Simon Barry J. (1647994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 10:02 AM | ImmunityBio (1326110) Subject Simon Barry J. (1647994) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/18/2026 4:20 PM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2026 6:32 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2026 6:37 AM | ImmunityBio (1326110) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/09/2026 6:39 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 7:03 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/02/2026 7:08 PM | CALIFORNIA CAPITAL EQUITY, LLC (1517764) Reporting Cambridge Equities, LP (1629222) Reporting ImmunityBio (1326110) Issuer MP 13 Ventures, LLC (1629186) Reporting Nant Capital, LLC (1675758) Reporting SOON-SHIONG PATRICK (1189020) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 7:24 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 7:12 PM | ImmunityBio (1326110) Issuer Simon Barry J. (1647994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 8:51 PM | Cambridge Equities, LP (1629222) Filed by ImmunityBio (1326110) Subject | Form SCHEDULE 13D/A | |
| 02/24/2026 7:03 PM | ImmunityBio (1326110) Issuer Simon Barry J. (1647994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 7:04 PM | Adcock Richard (1830328) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 7:05 PM | ImmunityBio (1326110) Issuer LAUER REGAN J (1200637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 7:05 PM | CALIFORNIA CAPITAL EQUITY, LLC (1517764) Reporting Cambridge Equities, LP (1629222) Reporting ImmunityBio (1326110) Issuer MP 13 Ventures, LLC (1629186) Reporting Nant Capital, LLC (1675758) Reporting SOON-SHIONG PATRICK (1189020) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 7:05 PM | ImmunityBio (1326110) Issuer Sachs David C. (1848899) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 7:05 PM | ImmunityBio (1326110) Issuer Selecky Christobel (1849739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your free book is about to disappear (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
| 02/23/2026 4:24 PM | ImmunityBio (1326110) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/23/2026 6:06 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/18/2026 8:02 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/12/2026 8:29 PM | CALIFORNIA CAPITAL EQUITY, LLC (1517764) Reporting Cambridge Equities, LP (1629222) Reporting ImmunityBio (1326110) Issuer MP 13 Ventures, LLC (1629186) Reporting Nant Capital, LLC (1675758) Reporting SOON-SHIONG PATRICK (1189020) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 7:50 PM | Adcock Richard (1830328) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 7:50 PM | ImmunityBio (1326110) Issuer LAUER REGAN J (1200637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 7:50 PM | ImmunityBio (1326110) Issuer Sachs David C. (1848899) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 6:00 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/21/2026 7:33 PM | ImmunityBio (1326110) Issuer Selecky Christobel (1849739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 7:34 PM | ImmunityBio (1326110) Issuer Simon Barry J. (1647994) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:29 PM | ImmunityBio (1326110) Subject Selecky Christobel (1849739) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/20/2026 10:05 AM | ImmunityBio (1326110) Subject Simon Barry J. (1647994) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/16/2026 3:22 PM | ImmunityBio (1326110) Subject Selecky Christobel (1849739) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/15/2026 7:35 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 7:42 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 5:10 PM | Adcock Richard (1830328) Reporting ImmunityBio (1326110) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 5:11 PM | ImmunityBio (1326110) Issuer Sachs David C. (1848899) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 4:54 PM | ImmunityBio (1326110) Issuer Wendel Bruce (1364846) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 12/16/2025 4:55 PM | ImmunityBio (1326110) Issuer Wendel Bruce (1364846) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:25 PM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/12/2025 6:01 AM | ImmunityBio (1326110) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |